The medications included in the program treat more than 80 conditions.

Overwhelmed or confused by AI and machine learning technology? A new analysis in European Heart Journal hopes to provide some clarity. 

Under the new proposal, the FDA would conduct an assessment of prevalent strains circulating each year, likely beginning around June, with the aim of new vaccines being ready by September. 

A team of cardiologists and cardiac surgeons collaborated on the new analysis, reviewing data from more than 50,000 patients and developing a new risk model for clinicians.  

The percentage of Americans who are postponing medical care has reached a new high, according to a recent Gallup poll.

Contrast-associated acute kidney injury is a significant problem in cardiology, especially among patients undergoing percutaneous coronary intervention. Can EHR-generated alerts make an impact?

The uninsured rate in the United States saw a drop from 11.1% in 2019 to 10.5% in 2021, according to a new report from the Department of Health and Human Services (HHS).

Pharmaceutical giant Pfizer is expanding its not-for-profit products, widening its existing initiative with the aim of lowering health inequities.